Thompson Rubinstein Investment Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $4.24M | Buy |
44,963
+653
| +1% | +$61.6K | 1.36% | 30 |
|
|
2018
Q4 | $2.84M | Buy |
44,310
+3,863
| +10% | +$248K | 1.05% | 36 |
|
|
2018
Q3 | $3.62M | Buy |
40,447
+6,612
| +20% | +$592K | 1.11% | 36 |
|
|
2018
Q2 | $2.69M | Buy |
33,835
+11,099
| +49% | +$881K | 0.9% | 40 |
|
|
2018
Q1 | $2.03M | Buy |
22,736
+8,004
| +54% | +$714K | 0.69% | 41 |
|
|
2017
Q4 | $1.54M | Buy |
+14,732
| New | +$1.54M | 0.51% | 47 |
|